Prostate Cancer Therapeutics Market, Global Outlook and Forecast 2023-2028

Report ID: 1139824 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Prostate Cancer Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Sale Channel
    1.3 Global Prostate Cancer Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Therapeutics Overall Market Size
    2.1 Global Prostate Cancer Therapeutics Market Size: 2021 VS 2028
    2.2 Global Prostate Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Prostate Cancer Therapeutics Players in Global Market
    3.2 Top Global Prostate Cancer Therapeutics Companies Ranked by Revenue
    3.3 Global Prostate Cancer Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Prostate Cancer Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Prostate Cancer Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Prostate Cancer Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Prostate Cancer Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Drugs
        4.1.3 Medical Devices
    4.2 By Type - Global Prostate Cancer Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Prostate Cancer Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Prostate Cancer Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Prostate Cancer Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacy
        5.1.3 Retail Pharmacy
        5.1.4 Online Sales
    5.2 By Sale Channel - Global Prostate Cancer Therapeutics Revenue & Forecasts
        5.2.1 By Sale Channel - Global Prostate Cancer Therapeutics Revenue, 2017-2022
        5.2.2 By Sale Channel - Global Prostate Cancer Therapeutics Revenue, 2023-2028
        5.2.3 By Sale Channel - Global Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Prostate Cancer Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Prostate Cancer Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Prostate Cancer Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Prostate Cancer Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Prostate Cancer Therapeutics Revenue, 2017-2028
        6.3.2 US Prostate Cancer Therapeutics Market Size, 2017-2028
        6.3.3 Canada Prostate Cancer Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Prostate Cancer Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Prostate Cancer Therapeutics Revenue, 2017-2028
        6.4.2 Germany Prostate Cancer Therapeutics Market Size, 2017-2028
        6.4.3 France Prostate Cancer Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Prostate Cancer Therapeutics Market Size, 2017-2028
        6.4.5 Italy Prostate Cancer Therapeutics Market Size, 2017-2028
        6.4.6 Russia Prostate Cancer Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Prostate Cancer Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Prostate Cancer Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Prostate Cancer Therapeutics Revenue, 2017-2028
        6.5.2 China Prostate Cancer Therapeutics Market Size, 2017-2028
        6.5.3 Japan Prostate Cancer Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Prostate Cancer Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Prostate Cancer Therapeutics Market Size, 2017-2028
        6.5.6 India Prostate Cancer Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Prostate Cancer Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Prostate Cancer Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Prostate Cancer Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Prostate Cancer Therapeutics Market Size, 2017-2028
        6.7.3 Israel Prostate Cancer Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Prostate Cancer Therapeutics Market Size, 2017-2028
        6.7.5 UAE Prostate Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Sanofi
        7.1.1 Sanofi Corporate Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Prostate Cancer Therapeutics Major Product Offerings
        7.1.4 Sanofi Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Sanofi Key News
    7.2 Pfizer
        7.2.1 Pfizer Corporate Summary
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Prostate Cancer Therapeutics Major Product Offerings
        7.2.4 Pfizer Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Pfizer Key News
    7.3 Amgen
        7.3.1 Amgen Corporate Summary
        7.3.2 Amgen Business Overview
        7.3.3 Amgen Prostate Cancer Therapeutics Major Product Offerings
        7.3.4 Amgen Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Amgen Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Prostate Cancer Therapeutics Major Product Offerings
        7.4.4 Johnson & Johnson Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 AstraZeneca
        7.5.1 AstraZeneca Corporate Summary
        7.5.2 AstraZeneca Business Overview
        7.5.3 AstraZeneca Prostate Cancer Therapeutics Major Product Offerings
        7.5.4 AstraZeneca Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 AstraZeneca Key News
    7.6 AbbVie
        7.6.1 AbbVie Corporate Summary
        7.6.2 AbbVie Business Overview
        7.6.3 AbbVie Prostate Cancer Therapeutics Major Product Offerings
        7.6.4 AbbVie Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 AbbVie Key News
    7.7 Bayer
        7.7.1 Bayer Corporate Summary
        7.7.2 Bayer Business Overview
        7.7.3 Bayer Prostate Cancer Therapeutics Major Product Offerings
        7.7.4 Bayer Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Bayer Key News
    7.8 Ipsen Group
        7.8.1 Ipsen Group Corporate Summary
        7.8.2 Ipsen Group Business Overview
        7.8.3 Ipsen Group Prostate Cancer Therapeutics Major Product Offerings
        7.8.4 Ipsen Group Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Ipsen Group Key News
    7.9 Endo Pharmaceuticals
        7.9.1 Endo Pharmaceuticals Corporate Summary
        7.9.2 Endo Pharmaceuticals Business Overview
        7.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Major Product Offerings
        7.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Endo Pharmaceuticals Key News
    7.10 Dendreon Corporation(Sanpower Group Co. Ltd.)
        7.10.1 Dendreon Corporation(Sanpower Group Co. Ltd.) Corporate Summary
        7.10.2 Dendreon Corporation(Sanpower Group Co. Ltd.) Business Overview
        7.10.3 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Major Product Offerings
        7.10.4 Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 Dendreon Corporation(Sanpower Group Co. Ltd.) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Prostate Cancer Therapeutics Market Opportunities & Trends in Global Market
    Table 2. Prostate Cancer Therapeutics Market Drivers in Global Market
    Table 3. Prostate Cancer Therapeutics Market Restraints in Global Market
    Table 4. Key Players of Prostate Cancer Therapeutics in Global Market
    Table 5. Top Prostate Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Prostate Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Prostate Cancer Therapeutics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Prostate Cancer Therapeutics Product Type
    Table 9. List of Global Tier 1 Prostate Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Sale Channel – Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Sale Channel - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Sale Channel - Prostate Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Prostate Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Prostate Cancer Therapeutics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Prostate Cancer Therapeutics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Prostate Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Prostate Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
    Table 30. Sanofi Corporate Summary
    Table 31. Sanofi Prostate Cancer Therapeutics Product Offerings
    Table 32. Sanofi Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 33. Pfizer Corporate Summary
    Table 34. Pfizer Prostate Cancer Therapeutics Product Offerings
    Table 35. Pfizer Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 36. Amgen Corporate Summary
    Table 37. Amgen Prostate Cancer Therapeutics Product Offerings
    Table 38. Amgen Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 39. Johnson & Johnson Corporate Summary
    Table 40. Johnson & Johnson Prostate Cancer Therapeutics Product Offerings
    Table 41. Johnson & Johnson Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 42. AstraZeneca Corporate Summary
    Table 43. AstraZeneca Prostate Cancer Therapeutics Product Offerings
    Table 44. AstraZeneca Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 45. AbbVie Corporate Summary
    Table 46. AbbVie Prostate Cancer Therapeutics Product Offerings
    Table 47. AbbVie Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 48. Bayer Corporate Summary
    Table 49. Bayer Prostate Cancer Therapeutics Product Offerings
    Table 50. Bayer Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 51. Ipsen Group Corporate Summary
    Table 52. Ipsen Group Prostate Cancer Therapeutics Product Offerings
    Table 53. Ipsen Group Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 54. Endo Pharmaceuticals Corporate Summary
    Table 55. Endo Pharmaceuticals Prostate Cancer Therapeutics Product Offerings
    Table 56. Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
    Table 57. Dendreon Corporation(Sanpower Group Co. Ltd.) Corporate Summary
    Table 58. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product Offerings
    Table 59. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Prostate Cancer Therapeutics Segment by Type in 2021
    Figure 2. Prostate Cancer Therapeutics Segment by Sale Channel in 2021
    Figure 3. Global Prostate Cancer Therapeutics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Prostate Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Prostate Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Therapeutics Revenue in 2021
    Figure 8. By Type - Global Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 9. By Sale Channel - Global Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 12. US Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 16. Germany Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 24. China Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 30. Brazil Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Prostate Cancer Therapeutics Revenue Market Share, 2017-2028
    Figure 33. Turkey Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Prostate Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
    Figure 37. Sanofi Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Pfizer Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Amgen Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Johnson & Johnson Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. AstraZeneca Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AbbVie Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Bayer Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Ipsen Group Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Endo Pharmaceuticals Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Dendreon Corporation(Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Prostate Cancer Therapeutics Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Prostate Cancer Therapeutics Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Prostate Cancer Therapeutics Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports